Managers / Q1 2021 · view latest →
Gates Foundation
CIK 0001663801 · 500 5TH AVE NORTH, SEATTLE, WA, 98109 · 206-709-3100
Summary
Gates Foundation reported $656M in U.S.-listed holdings across 7 positions for Q1 2021.
The portfolio is heavily concentrated: Curevac N V alone accounts for 43.7% of reported value.
Compared with Q4 2020, the fund opened 2 new positions and exited 0.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded, with multiple share classes and repeated sub-manager rows for the same issuer combined into one position — the same rule the holdings table uses by default. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Other · 43.7% · $287M
- Common Stock · 28.4% · $186M
- ADR · 27.9% · $183M
Quarter-over-Quarter Changes full breakdown →
vs Q4 2020 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| IMCRIMMUNCORE HLDGS PLC | NEW | +1.63M | 1.63M | +$69M | $69M |
| BFLYBUTTERFLY NETWORK INC | NEW | +1.01M | 1.01M | +$17M | $17M |
| VIRVIR BIOTECHNOLOGY INC | HELD | +0 | 2.78M | +$68M | $142M |
| CUREVAC N V | HELD | +0 | 3.13M | +$33M | $287M |
| BNTXBIONTECH SE | HELD | +0 | 1.04M | +$28M | $113M |
| AMYRIS INC | HELD | +0 | 292.4K | +$4M | $6M |
| ATRECA INC | HELD | +0 | 1.40M | −$2M | $21M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q1 2021
| # | Issuer | Class | % Portfolio | Value ↓ | Shares |
|---|---|---|---|---|---|
| 1 | CUREVAC N V | COM | 43.71% | $287M | 3.13M |
| 2 | VIRVIR BIOTECHNOLOGY INChistory → | COM | 21.71% | $142M | 2.78M |
| 3 | BNTXBIONTECH SEhistory → | SPONSORED ADS | 17.29% | $113M | 1.04M |
| 4 | IMCRIMMUNCORE HLDGS PLChistory → | ADS | 10.58% | $69M | 1.63M |
| 5 | ATRECA INC | CL A COM | 3.26% | $21M | 1.40M |
| 6 | BFLYBUTTERFLY NETWORK INChistory → | CL A COM | 2.59% | $17M | 1.01M |
| 7 | AMYRIS INC | COM NEW | 0.85% | $6M | 292.4K |
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q3 2024 | $44M | 5 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $60M | 6 | Aug 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $84M | 8 | May 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $90M | 8 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $84M | 9 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $126M | 9 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $113M | 9 | May 12, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $130M | 9 | Feb 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $127M | 10 | Nov 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $130M | 9 | Aug 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $186M | 11 | May 13, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $330M | 11 | Feb 11, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $342M | 10 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $692M | 8 | Aug 13, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $656M | 7 | May 14, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $438M | 5 | Feb 16, 2021 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.